Inovio Pharmaceuticals
INO
#8801
Rank
HK$1.20 B
Marketcap
HK$17.50
Share price
-1.32%
Change (1 day)
25.77%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.40. In 2024 the company made an earnings per share (EPS) of -HK$30.72 an increase over its 2023 EPS that were of -HK$47.36.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-26.93%
2024-HK$30.72-35.14%
2023-HK$47.36-56.62%
2022-HK$109.19-19.54%
2021-HK$135.7135.9%
2020-HK$99.86-11.57%
2019-HK$112.9215.24%
2018-HK$97.99-2.78%
2017-HK$100.796.93%
2016-HK$94.26134.88%
2015-HK$40.13-29.51%
2014-HK$56.93-57.34%
2013-HK$133.45146.55%
2012-HK$54.1320.83%
2011-HK$44.80-29.41%
2010-HK$63.46-48.48%
2009-HK$123.1910%
2008-HK$111.9911.11%
2007-HK$100.79-41.3%
2006-HK$171.72-66.91%
2005-HK$518.88110.61%
2004-HK$246.37-61.63%
2003-HK$642.07186.67%
2002-HK$223.98
2001N/A-100%
2000-HK$179.18-63.64%
1999-HK$492.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.38-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.19-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$9.72-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.24-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$59.06-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.97-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
HK$50.71-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA